PUBLISHER: DelveInsight | PRODUCT CODE: 2167735
PUBLISHER: DelveInsight | PRODUCT CODE: 2167735
MRI Devices Market Summary
Magnetic resonance imaging devices are diagnostic imaging systems that use strong magnetic fields, magnetic field gradients, and radiofrequency pulses to generate detailed cross-sectional images of the body's organs, soft tissues, and structures without ionizing radiation. MRI systems are classified by magnetic field strength, spanning low-to-mid-field systems below 1.5 tesla, high-field systems from 1.5 to 3 tesla, and very-high-field systems of 4 tesla and above, and by architecture, spanning closed, wide-bore, and open configurations. Leading systems include Siemens Healthineers' MAGNETOM family, GE HealthCare's SIGNA family, Philips' Ingenia and BlueSeal systems, Canon Medical's Vantage family, Fujifilm's open and dedicated systems, United Imaging's uMR platforms, Esaote's open and dedicated MRI systems, and portable low-field systems such as Hyperfine's Swoop. MRI is used across neurology, oncology, musculoskeletal, cardiovascular, gastroenterology, and other applications, in hospitals, diagnostic imaging centers, and other settings. Over the past decade, the field has advanced toward higher field strengths including 7 tesla, wide-bore designs for patient comfort, artificial intelligence-based image reconstruction and workflow, and helium-free or helium-conserving magnet technology that reduces cost and infrastructure requirements. Driven by the rising burden of chronic and age-related disease, expanding imaging volumes, and continuous technological innovation, MRI devices remain an essential and advancing pillar of modern diagnostic imaging.
MRI Devices Market Key Growth Drivers
Key Companies in MRI Devices Market
The competitive landscape is led by the following active developers and manufacturers of MRI devices:
Factors Contributing to the Growth of the MRI Devices Market
Market Drivers
Rising Burden of Neurological, Oncological, and Musculoskeletal Disease
The escalating burden of neurological, oncological, musculoskeletal, and cardiovascular disease is the foundational driver of MRI device demand. MRI provides superior soft-tissue contrast without ionizing radiation, making it the modality of choice for imaging the brain and spine, tumors, joints and soft tissues, and many other structures. The rising prevalence of neurological conditions such as stroke, dementia, and multiple sclerosis, the growing global cancer burden, and the high prevalence of musculoskeletal disorders expand the population requiring MRI. Cardiovascular and abdominal applications add further demand. As chronic and age-related diseases become more common worldwide, and as MRI plays an expanding role in their diagnosis, staging, and monitoring, demand for MRI imaging and systems continues to grow, reinforcing sustained market growth throughout the forecast period.
Aging Global Population
The aging of the global population is a powerful driver of MRI demand. Older adults carry a substantially higher prevalence of neurological, musculoskeletal, oncological, and cardiovascular conditions that require diagnostic imaging, and the number of people aged 60 and older is rising rapidly worldwide. This demographic shift expands the population requiring MRI for diagnosis and ongoing monitoring, and older patients often require repeated and more advanced imaging to guide management. The growth of age-related conditions such as dementia, degenerative joint and spine disease, and cancer increases MRI utilization. As populations continue to age and the burden of age-related disease grows, demographic trends are expected to be a significant driver of MRI device demand across the forecast period.
Market Restraints
Despite steady momentum, the MRI Devices market faces material constraints. The very high capital cost of MRI systems, particularly high-field and very-high-field systems, limits adoption, especially among smaller facilities and in resource-limited settings, and the substantial infrastructure, siting, and shielding requirements add further cost. Helium dependence has historically exposed the market to supply and cost pressures, though helium-free and helium-conserving magnets are mitigating this constraint. High operating and maintenance costs, including service contracts and specialized facilities, add to the total cost of ownership. Reimbursement pressure and cost-containment in many health systems constrain imaging volumes and capital purchases, and coverage varies across payers and countries. A shortage of trained radiologists and MRI technologists constrains capacity and utilization. Long equipment lifecycles and procurement cycles can slow new sales, and safety considerations related to strong magnetic fields, implants, and contrast agents add clinical and operational requirements. Rigorous and evolving regulatory requirements for medical imaging devices, including Food and Drug Administration clearance and the European Medical Device Regulation, add cost and complexity to product development and market entry. Finally, uneven infrastructure, service capacity, and affordability constraints in emerging markets can limit access and adoption across parts of the forecast period.
MRI Devices Market Segment Analysis
The MRI Devices Market is segmented by field strength (high-field mri systems, low-to-mid-field mri systems, very-high-field mri systems), architecture (closed mri systems, wide-bore mri systems, open mri systems), application (neurology, oncology, musculoskeletal, gastroenterology, others), end-user (hospitals, diagnostic centers, others), and geography (North America, Europe, Asia-Pacific, Rest of World).
By Field Strength
Dominant Subsegment: High-Field MRI Systems.
The high-field MRI systems segment accounted for 68% of the MRI Devices market in 2025. High-field systems, spanning 1.5 tesla to 3 tesla, dominate because they represent the clinical standard for the vast majority of diagnostic MRI, offering an optimal balance of image quality, scan speed, and clinical versatility across neurology, oncology, musculoskeletal, and cardiovascular applications. The 1.5 tesla and 3 tesla systems from Siemens Healthineers, GE HealthCare, Philips, Canon Medical, and United Imaging constitute the core of hospital and diagnostic center installations and generate the largest share of revenue. Low-to-mid-field systems below 1.5 tesla represent an important and evolving segment, including open systems for claustrophobic and larger patients and a new generation of portable, point-of-care low-field systems such as Hyperfine's Swoop that expand access to new settings. Very-high-field systems of 4 tesla and above, including 7 tesla systems such as Siemens Healthineers' MAGNETOM Terra, serve advanced clinical and research applications and are a small but growing segment. Nonetheless, the clinical dominance, versatility, and revenue scale of high-field systems secure the segment's leadership across the forecast period.
By Architecture
Dominant Subsegment: Closed MRI Systems.
The closed MRI systems segment accounted for 55% of the MRI Devices market in 2025. Closed, cylindrical-bore MRI systems dominate because they house the high-field superconducting magnets that deliver the highest image quality and the fastest scanning, making them the standard architecture for most diagnostic MRI. Closed systems from the leading manufacturers provide the field strength and gradient performance required across the full range of clinical applications and represent the largest share of installations and revenue. Wide-bore MRI systems, a variant of closed systems with a larger bore diameter, are a large and rapidly growing segment that improves patient comfort and access for larger, claustrophobic, and pediatric patients while retaining high field strength, and manufacturers have expanded wide-bore offerings across their portfolios. Open MRI systems, typically lower-field, serve claustrophobic and bariatric patients and specific applications, offered by manufacturers such as Fujifilm and Esaote, and dedicated extremity systems add further options. Nonetheless, the image quality, field strength, and clinical versatility of closed systems, reinforced by the growth of wide-bore designs, secure the segment's leadership across the forecast period.
MRI Devices Market Region Analysis
Dominant Region: North America
North America accounted for 38% of the global MRI Devices market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects advanced healthcare infrastructure, a high installed base of MRI systems, rapid adoption of new imaging technologies, and strong reimbursement. The United States leads on the strength of a large and well-equipped hospital and diagnostic imaging network, high imaging volumes, early adoption of high-field, wide-bore, artificial intelligence-enabled, and helium-efficient systems, and the presence of leading manufacturers and innovators including GE HealthCare and Hyperfine. Disease burden is substantial, with a high prevalence of neurological, oncological, and musculoskeletal conditions and an aging population. The regulatory environment is well established, with the Food and Drug Administration providing clearance pathways and a track record of clearing advanced MRI systems, including 7 tesla and portable low-field systems. Reimbursement supports MRI, and strong research infrastructure and capital investment further reinforce the market. This combination of infrastructure, technology adoption, and disease burden reinforces North America's leadership in the global market.
Fastest Growing Region: Asia-Pacific
Asia-Pacific is the fastest-growing region in the MRI Devices market. The region's elevated CAGR is driven by large populations, a rising burden of chronic and age-related disease, expanding healthcare access, and growing investment in imaging infrastructure across China, India, Japan, South Korea, and Southeast Asia. Many countries in the region have low MRI density relative to developed markets, creating substantial room for growth as hospitals and diagnostic centers expand imaging capacity. Rising incomes, growing insurance coverage, and government investment in healthcare are improving access to MRI, and domestic manufacturers such as United Imaging are expanding rapidly with high-field and value-tier systems. Rising disease burden, aging populations in several countries, and improving diagnosis rates further increase demand. Both multinational and regional manufacturers are expanding their presence and manufacturing. The combination of large populations, rising disease burden, low imaging density, and growing infrastructure positions Asia-Pacific as the highest-growth region over the forecast period.
Regional Commentary
North America
North America accounted for 38% of the global MRI Devices market revenue in 2025. The United States dominates the region on the strength of advanced healthcare infrastructure, a high installed base, rapid technology adoption, and the presence of leading manufacturers and innovators, while Canada contributes through its hospital networks and Mexico expands access within its growing healthcare sector.
Europe
Europe represents the second-largest regional market, led by Germany, France, and the United Kingdom. Growth is supported by a high disease burden, established imaging infrastructure, and the presence of major manufacturers such as Siemens Healthineers, Philips, and Esaote, while the European Medical Device Regulation shapes product requirements and market access across the region.
Asia-Pacific
Asia-Pacific is the fastest-growing region, propelled by large populations, a rising burden of chronic and age-related disease, expanding healthcare access, low MRI density, and growing investment in imaging infrastructure across China, India, Japan, South Korea, and Southeast Asia. Expanding domestic manufacturing, led by United Imaging, and value-tier systems are broadening access and adoption.
Rest of World
The Rest of World region, spanning the Middle East, Africa, and South America, is an emerging growth frontier. A rising burden of chronic disease, improving imaging infrastructure, and expanding healthcare investment are broadening adoption, while investment in hospitals and diagnostic centers supports growth from a low installed base.
MRI Devices Market Competitive Landscape
The MRI Devices market is classified as Consolidated. A small group of large medical imaging companies holds the majority of revenue, led by GE HealthCare, Siemens Healthineers, and Philips, with Canon Medical, Fujifilm, and the rapidly growing United Imaging holding significant positions, while Esaote, Hyperfine, Bruker, and Aspect Imaging serve open, portable, and specialized segments, and a field of regional players competes across the market. The competitive landscape can be evaluated across the following dimensions:
MRI Devices Market Recent Developmental Activities
In 2023 and 2024, GE HealthCare expanded its artificial intelligence-based image reconstruction, AIR Recon DL, across its MRI portfolio to accelerate scans and improve image quality. Strategic significance: Advances artificial intelligence-driven productivity and image quality across the installed base.
In 2023 and 2024, Siemens Healthineers expanded its Deep Resolve artificial intelligence reconstruction and its high-field and 7 tesla MAGNETOM portfolio, including MAGNETOM Terra.X. Strategic significance: Strengthens leadership in artificial intelligence and very-high-field imaging.
MRI Devices Market Segmentation
MRI Devices Market by Field Strength
MRI Devices Market by Architecture
MRI Devices Market by Application
MRI Devices Market by End-User
MRI Devices Market by Geography
Key Takeaways from the MRI Devices Market Report Study
Target audience that can benefit from this MRI devices market report study
Q1. What is the growth rate of the MRI Devices market?
The MRI Devices market is projected to expand at a CAGR of 6.54% during the forecast period of 2026-2034.
Q2. What is the market size of the MRI Devices market?
The MRI Devices market is estimated at USD 8.7 billion in 2025 and is projected to reach USD 15.5 billion by 2034.
Q3. Which region dominates the MRI Devices market?
North America dominated the MRI Devices market with a 38% share of global revenue in 2025, supported by advanced healthcare infrastructure, a high installed base, rapid technology adoption, supportive FDA pathways, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.
Q4. What are the key drivers of the MRI Devices market?
The principal drivers are the rising burden of neurological, oncological, and musculoskeletal disease; the aging global population; continuous technological advancement in artificial intelligence, field strength, and helium-efficient magnets; and growing diagnostic imaging volumes, reinforced by equipment replacement and upgrade cycles and expanding healthcare access in emerging markets.
Q5. Who are the major players in the MRI Devices market?
The major players include GE HealthCare Technologies Inc., Siemens Healthineers AG, Koninklijke Philips N.V., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, United Imaging Healthcare Co., Ltd., Esaote S.p.A., Hyperfine, Inc., Bruker Corporation, and Aspect Imaging Ltd., among other active manufacturers profiled in the Competitive Landscape section. GE HealthCare, Siemens Healthineers, and Philips lead the market, while United Imaging is a rapidly growing challenger.
For illustrative purposes, only the top 10 companies are listed in the Table of Contents. The report may include analysis and references to additional companies where relevant to the market assessment.